CH471829A - Verfahren zur Herstellung von 3-Hydroxy-1,5-bisdehydrosteroiden - Google Patents

Verfahren zur Herstellung von 3-Hydroxy-1,5-bisdehydrosteroiden

Info

Publication number
CH471829A
CH471829A CH5664A CH5664A CH471829A CH 471829 A CH471829 A CH 471829A CH 5664 A CH5664 A CH 5664A CH 5664 A CH5664 A CH 5664A CH 471829 A CH471829 A CH 471829A
Authority
CH
Switzerland
Prior art keywords
bisdehydrosteroids
hydroxy
preparation
Prior art date
Application number
CH5664A
Other languages
German (de)
English (en)
Inventor
P Oliveto Eugene
Tanabe Masato
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US251744A external-priority patent/US3127428A/en
Priority claimed from US251747A external-priority patent/US3127430A/en
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of CH471829A publication Critical patent/CH471829A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A63—SPORTS; GAMES; AMUSEMENTS
    • A63F—CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
    • A63F1/00—Card games
    • A63F1/06—Card game appurtenances
    • A63F1/18—Scoring or registering devices; Indicators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Multimedia (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH5664A 1963-01-16 1964-01-07 Verfahren zur Herstellung von 3-Hydroxy-1,5-bisdehydrosteroiden CH471829A (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US251744A US3127428A (en) 1963-01-16 1963-01-16 Process for converting a 3-keto-delta-steroid to the corresponding 3-keto delta-compound
US251747A US3127430A (en) 1963-01-16 1963-01-16 17alpha-methyl-1, 5-androstadienes-17beta-ol-3-one and derivatives thereof
US263441A US3332967A (en) 1963-01-16 1963-03-07 3-hydroxy-1, 5-bis-dehydro steroids and methods for their manufacture

Publications (1)

Publication Number Publication Date
CH471829A true CH471829A (de) 1969-04-30

Family

ID=27400477

Family Applications (1)

Application Number Title Priority Date Filing Date
CH5664A CH471829A (de) 1963-01-16 1964-01-07 Verfahren zur Herstellung von 3-Hydroxy-1,5-bisdehydrosteroiden

Country Status (9)

Country Link
US (1) US3332967A (https=)
BE (1) BE642575A (https=)
BR (1) BR6456127D0 (https=)
CH (1) CH471829A (https=)
DE (2) DE1793618C3 (https=)
DK (1) DK121120B (https=)
ES (1) ES295331A1 (https=)
FR (2) FR1602256A (https=)
SE (1) SE321468B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928398A (en) * 1973-11-01 1975-12-23 Richardson Merrell Inc Derivatives of 7{60 -methylestr-4-en-3{60 ,17{62 -diol
US4340538A (en) * 1980-07-21 1982-07-20 The Upjohn Company Process for producing 6α-fluoro-Δ1,4 -3-keto steroids
US4383947A (en) * 1981-07-24 1983-05-17 The Upjohn Company Introduction of a fluorine atom
US5879711A (en) * 1997-11-07 1999-03-09 Sequeira; Joel A. Stable antiandrogenic gel composition
CA2522784C (en) * 2003-04-01 2012-06-19 Hollis-Eden Pharmaceuticals, Inc. Antiandrogens with marginal agonist activity and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3127430A (en) * 1963-01-16 1964-03-31 Schering Corp 17alpha-methyl-1, 5-androstadienes-17beta-ol-3-one and derivatives thereof
US3127428A (en) * 1963-01-16 1964-03-31 Schering Corp Process for converting a 3-keto-delta-steroid to the corresponding 3-keto delta-compound

Also Published As

Publication number Publication date
DE1793618B2 (https=) 1975-03-06
SE321468B (https=) 1970-03-09
US3332967A (en) 1967-07-25
ES295331A1 (es) 1964-06-01
DE1793618C3 (de) 1975-10-23
BR6456127D0 (pt) 1973-07-17
BE642575A (https=)
DE1793618A1 (de) 1972-02-03
DK121120B (da) 1971-09-13
DE1493145B1 (de) 1971-11-25
FR4300M (https=) 1966-07-25
FR1602256A (en) 1970-11-02

Similar Documents

Publication Publication Date Title
CH463787A (de) Verfahren zur Herstellung von Polyiminolactonen
CH471134A (de) Verfahren zur Herstellung von Pyrazinoylbenzamidinen
CH469696A (de) Verfahren zur Herstellung von 2-Guanidino-alkylchromanen
CH466300A (de) Verfahren zur Herstellung von Dihydrotriazinen
CH438286A (de) Verfahren zur Herstellung von Dibenzocycloheptadien-ketoxim-O-äthern
CH449623A (de) Verfahren zur Herstellung von 4-Alkyl-5-cyan-oxazolen
CH457432A (de) Verfahren zur Herstellung von 2-Hydroxyäthyl-6,8-didesoxy-6-(1-methyl-4-propyl-pyrrolidin-carboxamido)-7-O-methyl-1-thio-D-erythro-D-galacto-octopyranosid
CH458329A (de) Verfahren zur Herstellung von 2-Alkylcyclopentan-1,3-dionen
AT244338B (de) Verfahren zur Herstellung von 3-Amino-isoxazolen
CH466272A (de) Verfahren zur Herstellung von Cycloalkylmethylaminobenzophenonen
CH440240A (de) Verfahren zur Herstellung von Fluorjodalkanen
CH471829A (de) Verfahren zur Herstellung von 3-Hydroxy-1,5-bisdehydrosteroiden
CH449610A (de) Verfahren zur Herstellung von Oestra-4,9-dien-3-olen
CH426836A (de) Verfahren zur Herstellung von Naphthindolizinchinonen
CH456579A (de) Verfahren zur Herstellung von Diphenylbenzocycloalkenen
CH430716A (de) Verfahren zur Herstellung von trans-2-Phenyl-3-methylmorpholin
CH450378A (de) Verfahren zur Herstellung von B-Hydroxyäthylthiocelestosaminid
CH470376A (de) Verfahren zur Herstellung von 17a-Äthinyl-19-nor-testosteron
CH432536A (de) Verfahren zur Herstellung von Diamino-monoazidotriazinen
CH416106A (de) Verfahren zur Herstellung von Polydodecalactam
CH425809A (de) Verfahren zur Herstellung von Pyridazoniminen
CH459973A (de) Verfahren zur Herstellung von Acetylacetamiden
CH447211A (de) Verfahren zur Herstellung von Diaminodihydroxy-anthrachinonen
AT266336B (de) Verfahren zur Herstellung von 3-Keto-4,6-bisdehydro-9-β,10α-steroiden
CH472397A (de) Verfahren zur Herstellung von 6-Halogen-1a,2a-methylen-16a-methyl- 4,6-pregnadien-17-ol-3,20-dionen

Legal Events

Date Code Title Description
PL Patent ceased